Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,680.00
+25.00 (1.51%)
Jun 16, 2026, 9:14 AM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 86.47 million as of June 15, 2026. Its market cap has decreased by -41.93% in one year.
Market Cap
86.47M
Enterprise Value
81.17M
Revenue
12.54M
Ranking
n/a
PE Ratio
11.78
Stock Price
1,680.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 86.47M, an increase of 778.11%. That is a compound annual growth rate of 14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 86.47M | -13.12% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 319.36M |
| Scancell Holdings | 202.37M |
| Faron Pharmaceuticals Oy | 91.30M |
| 4basebio | 81.26M |
| Ondine Biomedical | 67.54M |
| hVIVO | 58.05M |
| Hemogenyx Pharmaceuticals | 56.13M |
| Poolbeg Pharma | 54.29M |